# Boehringer Ingelheim Pharmaceuticals, Inc. – FDA Inspection, Jul 28, 2017

Source: https://www.keypedia.com/records/fda_inspections/boehringer-ingelheim-pharmaceuticals-inc/e3b667cd-82de-4b3a-a62c-e7c7a8a04994
Source feed: FDA_Inspections

> FDA inspection 1019749 of Boehringer Ingelheim Pharmaceuticals, Inc., July 28, 2017. 3 citations under 21 CFR part 314. Form 483 issued. 19 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1019749
- Company Name: Boehringer Ingelheim Pharmaceuticals, Inc.
- Inspection Date: 2017-07-28
- Project Area: Postmarket Surv. and Epidemiology
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: New England District Office
- Citation Count: 3

## Related Documents

- FDA Inspection 1334848 - 2026-08-25
- [FDA Inspection 1281125 - 2025-09-11](https://www.keypedia.com/records/fda_inspections/boehringer-ingelheim-pharmaceuticals-inc/9c62d459-d5fc-4614-8d41-987968509962)
- FDA Inspection 1235545 - 2024-05-02
- FDA Inspection 1219707 - 2023-09-22
- [FDA Inspection 1112627 - 2019-12-12](https://www.keypedia.com/records/fda_inspections/boehringer-ingelheim-pharmaceuticals-inc/3cec078a-63a0-4054-aba3-a7b39a8fad4e)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/christopher-janik/2803fa51-5259-4632-93ad-c6f038bd2fd4)

Company: https://www.keypedia.com/companies/boehringer-ingelheim-pharmaceuticals-inc/437c28a1-054f-4c22-9dba-fd40af58a7be

Office: https://www.keypedia.com/offices/new-england-district-office/aa458072-2f1d-4231-89f5-21ba7a3b7144